Open Access
E3S Web Conf.
Volume 218, 2020
2020 International Symposium on Energy, Environmental Science and Engineering (ISEESE 2020)
Article Number 02016
Number of page(s) 8
Section New Energy Development and Energy Sustainable Development Optimization
Published online 11 December 2020
  1. Kangmei Pharmaceuticals. kangmei Pharmaceuticals’ Announcement on Corrections to Pre-Accounting Errors [EB/OL]., 2019-0430 [Google Scholar]
  2. ST Kangmei. Special Notes on Inquiries on Matters reported by Kangmei Pharmaceutical Co., Ltd. [EB/OL]., 2019-05-29. [Google Scholar]
  3. ST Kangmei. Notice of receipt of the Notice of Administrative Penalties and Market Ban// from the China Securities Regulatory Commission [EB/OL]., 2019-08-17. [Google Scholar]
  4. Shizhong huang. Analysis on the Extension of Kangmei Pharmaceutical’s Financial Fraud. Finance and Accounting monthly, 2019(17):3-6+178. [Google Scholar]
  5. Xiayun Song, Bowen Tan. A Case Study of zhongzhong Zhujiang Accounting Firm’s audit failure on Kangmei Pharmaceutical. Commercial Accounting, 2019(22):4-8. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.